Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2025-02-01 Investor Presentation
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on the unaudited Financial Results of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.' It references unaudited financial results for the quarter and nine months ended December 31, 2024, and includes detailed financial performance data, business overview, and strategic updates. The content is a presentation format aimed at investors and stakeholders, focusing on financials, strategy, and market position. It is not a brief announcement or a certification letter, nor is it a full annual or interim report with comprehensive financial statements. Therefore, the document fits the category of an Investor Presentation (IP).
2025-02-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on the unaudited Financial Results of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.' It references unaudited financial results for the quarter and nine months ended December 31, 2024, and includes detailed financial performance data, business overview, and strategic updates. The document is a presentation format aimed at investors and stakeholders, focusing on financials, strategy, and market position. It is not a brief announcement or a certification letter, nor is it a full annual or interim report with comprehensive financial statements. Therefore, the document fits the category of an Investor Presentation (IP).
2025-02-01 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated February 1, 2025, announcing the unaudited financial results of Neogen Chemicals Limited for the quarter and nine months ended December 31, 2024. It includes detailed financial performance metrics such as revenue, EBITDA, profit after tax, and EPS, along with management commentary and updates on expansion initiatives. The document is not a full annual or interim report but a press release summarizing quarterly financial results. It is not a transcript, audit report, or regulatory filing. The presence of detailed financial data and performance analysis for a quarter indicates it is an Earnings Release (ER). Q3 2025
2025-02-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on the unaudited Financial Results of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.' It references unaudited financial results for the quarter and nine months ended December 31, 2024, and includes detailed financial performance data, business overview, leadership team, and expansion initiatives. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content matches the characteristics of an investor presentation focusing on financials, strategy, and market position rather than a brief earnings release or regulatory filing. Therefore, the appropriate classification is Investor Presentation (IP).
2025-02-01 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on the unaudited Financial Results of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.' It references unaudited financial results for the quarter and nine months ended December 31, 2024, and includes detailed financial performance data, business overview, and strategic updates. The document is a presentation format aimed at investors and stakeholders, focusing on financials, strategy, and market position. It is not a brief announcement or a certification, nor is it a full annual or interim report with comprehensive financial statements. Therefore, the document fits the category of an Investor Presentation (IP).
2025-02-01 English
Integrated Filing- Financial
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Neogen Chemicals Limited regarding the outcome of a Board Meeting held on February 1, 2025. It includes the approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, pursuant to SEBI Listing Regulations. The document contains the financial results themselves, along with an Independent Auditor's Limited Review Report on these interim financial results. The presence of unaudited financial statements for a period shorter than a full fiscal year (quarter and nine months) and the auditor's review report indicates this is an Interim / Quarterly Report. The document is about actual financial data and analysis, not merely an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2025-02-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.